Anti-proliferative actions of N '-desmethylsorafenib in human breast cancer cells

Publisher:
Pergamon-Elsevier Science Ltd
Publication Type:
Journal Article
Citation:
Biochemical Pharmacology, 2013, 86 (3), pp. 419 - 427
Issue Date:
2013-01
Full metadata record
Files in This Item:
Filename Description Size
2013001065OK.pdf1.9 MB
Adobe PDF
d The multi-kinase inhibitor sorafenib is used for the treatment of renal and hepatic carcinomas and is undergoing evaluation for treatment of breast cancer in combination with other agents. Cytochrome P450 (CYP) 3A4 converts sorafenib to multiple metabo
Please use this identifier to cite or link to this item: